Seeking Alpha

Michael Sweeney's  Instablog

Michael Sweeney
Send Message
Michael Sweeney is an investor in and advocate of Bitcoin. is a bitcoin fund set up to invest in Bitcoin and digital currency opportunities. The fund will NOT have a traditional bank account as investments and distributions are 100% in bitcoin. Current investments and opportunities... More
My company:
  • Unilife Corporation (NASDAQ: UNIS; ASX; UNS) - July 21, 2010 Update 0 comments
    Jul 21, 2010 10:55 PM | about stocks: UNIS

    Unilife Full OutsideIn Research Report

    Unilife Corporation Update (Nasdaq: UNIS, ASX: UNS) – July 21, 2010

    Since my last update on May 18, 2010, there have been a number of significant milestones reached at Unilife. Unilife Corporation’s CEO is Alan Shortall, and the Company is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. In the last two months Unilife has:

    • Signed an exclusivity list with sanofi-aventis;
    • Management has indicated that there have been “accelerating discussions with other pharmaceutical companies”;
    • Alan Shorthall’s management team continues to expand with Rich Wieland joining as CFO and Christopher Naftzger

    Russell 3000®, Russell Microcap® and Russell Global® Indexes 

    Unilife was added to the Russell 3000®, Russell Microcap® and Russell Global® indexes in the U.S. as of Friday, June 25, 2010. This was very significant for Unilife as they move to a more balanced institutional and retail shareholder base. Many institutional funds have limitations on who they can invest in. Inclusion on the Russell indexes opens up the institutional market for Unilife.

    The Russell 3000® Index is comprised principally of the 3,000 largest and most liquid stocks based and traded in the U.S. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes. Membership in the Russell indexes remains in place for one year. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading US$3.9 trillion in assets currently are benchmarked to the Russell indexes. These investment tools originated from Russell's multi-manager investment business in the early 1980s when the company saw the need for a more objective, market-driven set of benchmarks in order to evaluate outside investment managers.

    Seeking Alpha – Doug Landy

    An independent colleague of mine Doug Landy at Seeking Alpha wrote a very interesting and informative update on Unilife’s “Potential Milestones.” His list of achieved and potential milestones includes:

    Potential Milestones for Unilife

    • Unilife expects to complete construction of the York, Pennsylvania, facility in late 2010.
    • Unilife aims to employ approximately 200 individuals by the end of 2010.
    • The industrialization program with Sanofi-Aventis is on track to be completed one year ahead of schedule (late 2010). Supply of the Unifill Syringe to Sanofi-Aventis could begin upon the completion of the industrialization program, with a high-volume automated assembly system is expected to be established by the end of 2011.
    • During 2010, Unilife expects to begin to formalize additional relationships with a number of other pharmaceutical companies that wish to use the Unifill Syringe in areas not designated as exclusive to Sanofi-Aventis.
    • Unilife intends to begin full commercial supply of its Unitract 1ml Syringe during the first half of 2010 and to secure further distribution agreements for this line of syringes in the U.S. and overseas.


    Alan Shortall and Unilife continue to expand their management team. Christopher Naftzger joined as General Counsel, Corporate Secretary and Chief Compliance Officer, and he will provide the management team and Board of Directors of Unilife with counsel on all international, legal and government matters as well as corporate finance and SEC regulation. Prior to joining Unilife, Naftzger served on the senior management team as assistant general counsel and assistant secretary of Chesapeake Corporation, a global supplier of packaging to the pharmaceutical, healthcare and consumer industries. Naftzger has also served as the senior counsel at Koch Industries, Inc, the second largest privately held company in the U.S. with revenues of approximately $98 billion in 2008, and as a partner at Blank Rome LLP, a full service international law and government affairs firm. He holds a juris doctorate from Willamette University College of Law in Oregon, and a bachelor's degree from Hampden-Sydney College in Virginia.

    Richard Wieland II joined as Unilife’s Executive Vice President and Chief Financial Officer (NASDAQ:CFO). Wieland will oversee the management of Unilife's finance and accounting, human resources and IT operations. Wieland has over 30 years of senior financial experience with U.S.-based public and private companies. He has served as the CFO of four NASDAQ-listed companies within the life sciences industry, and as a senior executive of two New York Stock Exchange-listed companies. Most recently, Mr. Wieland served as the CFO of Cytochroma Inc., a privately-held specialty pharmaceutical company. From 2004 to 2008, Mr. Wieland served as Executive Vice-President and CFO of Advanced Life Sciences Holdings, Inc., a NASDAQ-listed clinical-stage biopharmaceutical company. Prior to that, Mr. Wieland served as a senior executive of other NASDAQ-listed life science and healthcare companies, including Option Care, Inc., where he was a Board member, President and Chief Operating Offer. Wieland received his MBA from Washington University in St. Louis, MO, and his BA in Accounting and Economics from Monmouth College in Monmouth, IL, where he later served as a member of the Board of Trustees. Mr. Wieland is a past member of the National Investor Relations Institute, Financial Executives International and the U.S. Army Signal Corps.

    Disclosure: no position
    Themes: unilife, alan shortall Stocks: UNIS
Back To Michael Sweeney's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.